Chas Pulido is a third-generation healthcare CEO turned venture capitalist at Alix Ventures who has been an early champion of TechBio as a distinct investment category, focusing on companies at the intersection of engineering, computation, and biology. Beyond investing, he built BIOS as a standalone TechBio media and community platform that includes a top-ranked podcast, 25K+ subscriber newsletter, and the world's first TechBio angel syndicate. Chas Pulido is a third-generation healthcare CEO turned venture capitalist at Alix Ventures who has been an early champion of TechBio as a distinct investment category, focusing on companies at the intersection of engineering, computation, and biology. Beyond investing, he built BIOS as a standalone TechBio media and community platform that includes a top-ranked podcast, 25K+ subscriber newsletter, and the world's first TechBio angel syndicate.